Genetic testing identifies germline mutations, while genomic testing analyzes somatic mutations in tumors, influencing treatment options. Broader testing criteria are expanding access to genetic ...

When it comes to breast cancer, you always hear that early detection is key. Thanks to Nikki Coolman’s proactive approach, ...

"The collaboration with Tempus will substantially augment our existing precision oncology capabilities. Northwestern Medicine will now offer next-generation sequencing to patients with earlier-stage ...

Medicare-eligible patients with advanced cancers will have access to genomic tests under a national coverage determination CMS finalized March 16. The determination covers next-generation sequencing ...

The Urology Care Foundation and the Prostate Cancer Foundation have created a new educational guide on genetic tests to guide ...

For the more than 300,000 women diagnosed with breast cancer each year, one of the biggest challenges is uncertainty around treatment options. Treatment isn’t one-size-fits-all and often comes with ...

For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...

We are at a transformative moment in oncology. Remarkable advancements have led to the identification of biomarkers that can predict treatment response, tests that can detect cancer risk before ...

Tens of thousands of patients with lung cancer in the United Kingdom are missing out on targeted treatment that could improve their prognosis due to delays in genomic testing, a new report has warned.